Compare RVTY & EVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RVTY | EVR |
|---|---|---|
| Founded | 1937 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.9B | 11.7B |
| IPO Year | N/A | 2006 |
| Metric | RVTY | EVR |
|---|---|---|
| Price | $100.79 | $331.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 9 |
| Target Price | $112.92 | ★ $320.11 |
| AVG Volume (30 Days) | ★ 1.7M | 344.0K |
| Earning Date | 10-27-2025 | 10-29-2025 |
| Dividend Yield | 0.28% | ★ 1.01% |
| EPS Growth | N/A | ★ 61.11 |
| EPS | 1.99 | ★ 12.55 |
| Revenue | $2,813,367,000.00 | ★ $3,542,875,000.00 |
| Revenue This Year | $5.33 | $25.39 |
| Revenue Next Year | $3.07 | $16.43 |
| P/E Ratio | $51.70 | ★ $26.43 |
| Revenue Growth | 3.37 | ★ 27.03 |
| 52 Week Low | $81.36 | $148.63 |
| 52 Week High | $128.29 | $364.42 |
| Indicator | RVTY | EVR |
|---|---|---|
| Relative Strength Index (RSI) | 57.32 | 62.83 |
| Support Level | $99.35 | $310.93 |
| Resistance Level | $104.84 | $322.82 |
| Average True Range (ATR) | 3.06 | 11.11 |
| MACD | 0.33 | 3.21 |
| Stochastic Oscillator | 66.03 | 87.16 |
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
Evercore is a leading independent investment banking advisory firm that generates most of its revenue through merger and acquisition and restructuring advisory services, with much smaller capital raising, equities trading, and investment management businesses. Founded in 1995, it has built a reputation for advising on some of the world's largest and most complex transactions. The firm operates globally with a strong presence in the US and Europe, serving corporations, financial sponsors, and government clients. Its business model emphasizes high-touch, conflict-free advice rather than balance sheet lending, allowing it to compete with larger bulge-bracket banks.